Novavax NVAX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $240.63M-54.6% | $530.23M-6.7% | $568.51M-57.5% | $1.34B-11.8% | ||
| $494.45M+25.9% | $392.89M— | $0— | —— | ||
| $10.88M+2.4% | $10.63M+1.9% | $10.42M+1.2% | $10.3M-10.3% | ||
| $45.56M+7.6% | $42.34M-74.9% | $168.96M-65.0% | $482.06M+5,334% | ||
| $26.82M-65.7% | $78.16M-65.4% | $226.02M-4.7% | $237.15M+44.0% | ||
| $87.51M— | $0— | —— | —— | ||
| $978.28M-13.3% | $1.13B-1.3% | $1.14B-32.8% | $1.7B-21.0% | ||
| $44.8M-67.6% | $138.41M-54.7% | $305.77M+3.9% | $294.25M+30.3% | ||
| $113.46M+5.6% | $107.48M-15.7% | $127.45M+0.9% | $126.33M-3.9% | ||
| $17.08M-28.8% | $24M-31.7% | $35.16M+23.5% | $28.47M+17.2% | ||
| $1.18B-24.6% | $1.56B-13.2% | $1.8B-20.4% | $2.26B-12.3% | ||
| $24.58M-40.9% | $41.58M-68.6% | $132.61M-38.8% | $216.52M+70.4% | ||
| $137.78M-37.3% | $219.6M-74.5% | $861.41M-7.4% | $930.06M+2,479% | ||
| $140.05M-79.3% | $675.07M+180% | $241.31M-34.8% | $370.14M-73.6% | ||
| $2.51M-64.2% | $7.01M+36.3% | $5.14M-81.1% | $27.2M-79.2% | ||
| $9.88M-2.1% | $10.09M-56.1% | $22.98M+36.2% | $16.87M-45.6% | ||
| $2.51M-64.2% | $7.01M+36.3% | $5.14M-81.1% | $27.2M-79.2% | ||
| $47.87M— | $0— | —— | —— | ||
| $358.94M-19.7% | $446.82M-28.2% | $622.21M+247% | $179.41M+4.0% | ||
| $459.95M-60.2% | $1.15B-29.4% | $1.64B-33.5% | $2.46B+2.9% | ||
| $244.21M— | —— | —— | —— | ||
| $2.09M-96.1% | $53.73M-3.9% | $55.92M+79.0% | $31.24M— | ||
| $239.07M-33.5% | $359.61M+985% | $33.13M-40.5% | $55.7M+32.2% | ||
| $1.3B-40.3% | $2.18B-13.1% | $2.51B-13.1% | $2.89B-1.2% | ||
| $0— | $0— | $0— | $0— | ||
| $1.65M+1.9% | $1.62M+15.2% | $1.41M+61.9% | $868K+13.6% | ||
| $4.54B+0.9% | $4.5B+7.4% | $4.19B+12.2% | $3.74B+11.5% | ||
| -$4.57B+8.8% | -$5.01B-3.9% | -$4.82B-12.7% | -$4.28B-18.2% | ||
| $2.01M+109% | -$22.56M-929% | $2.72M+143% | -$6.38M-371% | ||
| $103.02M+7.5% | $95.85M+3.9% | $92.27M+1.8% | $90.66M+6.5% | ||
| -$127.75M+79.5% | -$623.84M+13.0% | -$716.93M-13.1% | -$634.08M-80.3% | ||
| $1.18B-24.6% | $1.56B-13.2% | $1.8B-20.4% | $2.26B-12.3% | ||
| —— | —— | —— | —— | ||
| $494.45M+25.9% | $392.89M— | $0— | —— | ||
| $17.08M-28.8% | $24M-31.7% | $35.16M+23.5% | $28.47M+17.2% | ||
| $22.9M-85.8% | $161.59M-12.8% | $185.22M+74.3% | $106.24M+165% | ||
| $17.08M-28.8% | $24M-31.7% | $35.16M+23.5% | $28.47M+17.2% | ||
| $17.08M-28.8% | $24M-31.7% | $35.16M+23.5% | $28.47M+17.2% | ||
| $358.94M-19.7% | $446.82M-28.2% | $622.21M+247% | $179.41M+4.0% | ||
| $107.17M-49.3% | $211.17M-46.5% | $394.67M-33.2% | $591.16M-12.3% | ||
| $107.17M-49.3% | $211.17M-46.5% | $394.67M-33.2% | $591.16M-12.3% | ||
| $137.78M-37.3% | $219.6M-74.5% | $861.41M-7.4% | $930.06M+2,479% | ||
| $358.94M-19.7% | $446.82M-28.2% | $622.21M+247% | $179.41M+4.0% | ||
| $358.94M-19.7% | $446.82M-28.2% | $622.21M+247% | $179.41M+4.0% | ||
| $280.56M+178% | $100.8M-42.0% | $173.68M-5.5% | $183.82M-44.5% | ||
| $1.65M+1.9% | $1.62M+15.2% | $1.41M+61.9% | $868K+13.6% | ||
| $0— | $0— | $0— | $0— | ||
| $106.45M-1.7% | $108.29M-63.6% | $297.24M+261% | $82.38M-81.9% | ||
| $2.51M-64.2% | $7.01M+36.3% | $5.14M-81.1% | $27.2M-79.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Novavax's total assets?
- Novavax (NVAX) holds $1.0B in total assets, down 19.3% year over year.
- How much debt does Novavax have?
- Novavax carries $295.1M in total debt against -$144.8M of shareholders' equity, a debt-to-equity ratio of 1.54.
- How much cash does Novavax have?
- Novavax holds $228.4M in cash and equivalents.
- Can Novavax cover its short-term obligations?
- Its current ratio is 2.48 — current assets exceed current liabilities.
- Where does Novavax's balance sheet data come from?
- Every line is extracted from Novavax's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
